Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
NCT ID: NCT00295906
Last Updated: 2013-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
4550 participants
INTERVENTIONAL
2004-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This randomized clinical trial is studying how well computer-based continuing education courses work in improving doctors' ability to perform skin cancer or weight control exams and counseling during routine office visits.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* Compare the efficacy of a continuing education course designed to improve primary care physician performance in examination and counseling of patients about skin cancer vs a continuing education course designed to improve physician assessment of weight management.
* Evaluate physician performance of skin examination during routine patient visits at 12 months after completion of the skin cancer continuing education course.
* Evaluate physician counseling around skin cancer issues.
Secondary
* Evaluate the efficacy of the skin cancer continuing education course in improving physician skin cancer triage skills and in changing physician attitudes and knowledge regarding skin cancer issues.
* Assess improvements in physician assessment of weight, diet, and physical activity.
OUTLINE: This is a randomized, multicenter study. Physicians are stratified according to participating center. Physicians are randomized to 1 of 2 intervention arms.
* Arm I (skin cancer continuing education course): Physicians complete a 1-hour continuing education course on skin cancer. The course is available to the physician as a reference for up to 12 months. Physicians complete an online test at baseline, immediately after the course is completed, and at 1 month and 12 months after course completion to assess their knowledge, attitudes, skill, and practices towards skin examination and skin cancer counseling.
Patients are interviewed by telephone within 1 week after a routine office visit with their physician to assess the physician's skin assessment and skin cancer counseling practices. The interviews are conducted prior to and at 1 month and 12 months after the physician completes the continuing education course.
* Arm II (weight control continuing education course): Physicians complete a 1-hour continuing education course on weight, dietary, and physical activity assessment and counseling. The course is available to the physician as a reference for up to 12 months. Physicians complete an online test at baseline, immediately after the course is completed, and at 1 month and 12 months after course completion to assess their knowledge, attitudes, skill, and practices towards weight, dietary, and physical activity assessment and counseling.
Patients are interviewed by telephone within 1 week after a routine office visit with their physician to assess the physician's weight, dietary, and physical activity assessment and counseling practices. The interviews are conducted prior to and at 1 month and 12 months after the physician completes the continuing education course.
PROJECTED ACCRUAL: A total of 50 physicians and 4,500 patients will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
educational intervention
internet-based intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary care physician, meeting all of the following criteria:
* General internist or family physician
* Must devote at least 75% of their time to primary care practice
* At least 1 year in practice
* Must be in a community-based practice with no more than 1 participating physician per practice
* Must not be planning to retire within the next 2 years
* Has a patient population that is predominantly at substantial risk of melanoma and other skin cancers (i.e., adults whose non-sun-exposed skin color is white or tan, but not brown)
* Patient
* Adult who is scheduled for a routine office visit with a study physician
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* Not specified
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Rhode Island Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin A. Weinstock, MD, PhD
Role: STUDY_CHAIR
Rhode Island Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scripps-Ranch Family Medicine Clinic at University of California
San Diego, California, United States
University of Kansas School of Medicine - Wichita
Wichita, Kansas, United States
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
Rhode Island Hospital Comprehensive Cancer Center
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Martin L. Kabongo, MD, PhD
Role: primary
Ken J. Kallail, PhD
Role: primary
Ohio State University Cancer Clinical Trial Matching Service
Role: primary
Clinical Trials Office - Kimmel Cancer Center at Thomas Jeffer
Role: primary
Clinical Trials Office - Rhode Island Hospital Comprehensive C
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIH-1050258954A1
Identifier Type: -
Identifier Source: secondary_id
RIH-0348-03
Identifier Type: -
Identifier Source: secondary_id
CDR0000454721
Identifier Type: -
Identifier Source: org_study_id